Urinary nandrolone metabolite detection after ingestion of a nandrolone precursor

Medicine and Science in Sports and Exercise

Volumn 41, Issue 4, 2009, Pages 766-772

  Watson, Phillip ^a   Judkins, Catherine ^b   Houghton, Ed ^b   Russell, Caroline ^b   Maughan, Ronald J ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b HFL Sport Science   (United Kingdom)

Author keywords

19 Norandrostenedione; Drugs in sport; Steroids; World anti doping agency

Indexed keywords

19 NORANDROSTERONE; 19 NORETIOCHOLANOLONE; BOLANDIOL; CREATINE; ESTR 4 ENE 3,17 DIONE; NANDROLONE; UNCLASSIFIED DRUG; WATER;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPING; FEMALE; HUMAN; INGESTION; KIDNEY CONCENTRATING CAPACITY; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; URINALYSIS; URINARY EXCRETION; URINE LEVEL; VOLUNTEER;

ADULT; ANDROSTENEDIONE; CREATINE; DOPING IN SPORTS; ESTRANES; FEMALE; HUMANS; MALE; NANDROLONE; YOUNG ADULT;

EID: 67650091981     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e31818edaeb     Document Type: Article

References (21)

1. Avois L, Mangin P, Saugy M. Concentrations of nandrolone metabolites in urine after the therapeutic administration of an ophthalmic solution. J Pharm Biomed Anal. 2007;44:173-9.
2. Ayotte C, Guay C, Cleroux M, Goudereault D, Fakirian A. Origin of elevated levels of norandrosterone in human urine: half-truths vs facts. In: Schanzer W, Geyer H, Gotzmann A, Mareck U, editors. Recent Advances in Doping Analysis (10). Koln: Sport und Buch StrauB; 2002. p. 13-21.
3. Baume N, Avois L, Schweizer C, et al. [13C]Nandrolone excretion in trained athletes: interindividual variability in metabolism. Clin Chem. 2004;50:355-64.
4. Catlin DH, Leder BZ, Ahrens B, et al. Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite. JAMA. 2000;284:2618-21.
5. Delbeke F, van Eenoo P, van Thuyne W, Desmet N. Prohormones and sport. J Steroid Biochem Mol Biol. 2002;83:245-51.
6. Geyer H, Mareck-Engelke U, Reinhart U, Thevis M, Schanzer W. Positive doping cases with norandrosterone after application of contaminated nutritional supplements. Dtsch Z Sportmed.2000;51:378.
7. Geyer H, Parr MK, Mareck U, Reinhart U, Schrader Y, Schanzer W. Analysis of non-hormonal nutritional supplements for anabol- ic-androgenic steroids-results of an international study. Int J Sports Med. 2004;25:124-9.
8. Hemmersbach P, Hagensen AH, Misund J. Determination of urinary norandrosterone excretion in females during one menstrual cycle by gas chromatography/mass spectrometry. Biomed Chromatogr. 2006;20:710-7.
9. Judkins C, Watson P, Russell C. A crossover study of 19-nor- androstenedione contamination in sports supplements: preliminary findings. In: Schanzer W, Geyer H, Gotzmann A, Marek U, editors. Recent Advances in Doping Analysis. Vol 14. Koln:Sportverlag Strauss; 2006. p. 477-80.
10. Lambert MI, St Clair Gibson A. Anabolic-androgenic steroids: effects on muscle size and strength. S Afr J Sports Med. 1995;2:6-9.
11. Lentner C. Geigy Scientific Tables, Volume 1. Basel: Ciba-GeigyLimited; 1981. p. 274.
12. Machnik M, Schrader Y, Schanzer W. Plasma levels of 19- norsteroids after oral and buccal administration of norandrostene- dione. In: Schanzer W, Geyer H, Gotzmann A, Mareck U, editors. Recent advances in doping analysis (10). Koln: Sport und Buch StrauB; 2002. p. 125-32.
13. Maughan RJ. Contamination of dietary supplements and positive drugs tests in sport. J Sports Sci. 2005;23:883-9.
14. Maughan RJ, Nadel ER. Temperature regulation and fluid and electrolyte balance. In: Maughan RJ, editor. Nutrition in Sport.Oxford (UK): Blackwell Science; 2000. p. 203-15.
15. Noakes TD. Tainted glory-doping and athletic performance. N Engl J Med. 2004;351:847-9.
16. Tseng YL, Kuo F-H, Sun H-H. Quantification and profiling of 19-norandrosterone and 19-noretiocholanolone in human urine after consumption of a nutritional supplement and norsteroids. J Anal Toxicol. 2005;29:124-34.
17. Uralets VP, Gillette PA. Over-the-counter anabolic steroids 4- androsten-3,17-dione; 4-androstene-3beta,17beta-diol; and 19- nor-4-androsten-3,17-dione: excretion studies in men. J Anal Toxicol. 1999;23:357-66.
18. Van der Merwe PJ, Grobbelaar E. Unintentional doping through the use of contaminated nutritional supplements. S Afr Med J. 2005;95:510.
19. van Gammeren D, Falk D, Antonio J. Effects of norandrostene- dione and norandrostenediol in resistance-trained men. Nutrition. 2002;18:734-7.
20. Dumasia MC. In vivo biotransformation of17a-methyltestoserone in the horse revisited: identification of 17-hydroxymethyl metabolites in equine urine by capillary gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2003;17:320-9.
21. Shackleton CHL, Whitney JO. Use of Sep-Pak cartridges for urinary steroid extraction. Evaluation of the method for use prior to gas chromatographic analysis. Clin Chim Acta. 1980;107: 231-43.